March 27th 2024
March 14th 2024
By Sponsored by Amgen
January 30th 2024
By This article is sponsored by Ipsen Biopharmaceuticals, Inc.
When Bob was first diagnosed and treated for follicular lymphoma, he refused to let the fear of the cancer returning dominate his life. Nearly 25 years later—after having experienced a relapse—Bob is still in remission and chooses to live his life to the fullest and celebrate life’s joys every day.
December 19th 2023
December 1st 2023
November 7th 2023
This episode of the Cancer Horizons podcast features genitourinary oncologist Ulka Vaishampayan, MBBS, and is sponsored by Bristol Myers Squibb.
October 11th 2023
By Sponsored Content
March 9th 2023
A new survey from HealthTree Foundation and Adaptive Biotechnologies shows that patients with multiple myeloma report significant clinical and emotional benefits from MRD testing and 90% of patients who have had MRD testing would recommend it to others, underscoring its benefits and providing support for broad clinical use.
March 6th 2023
March 2nd 2023
The Essence of Oncology Nursing
The Powerful Storm Cancer Brings
Keytruda Combo Boosts Survival in Gastric Cancer Subtype
Approaching My 10-Year Cancerversary with Male Breast Cancer